Please assess the completion status of the following clinical trial:

Trial Title: Pharmacy Home Adherence Reporting and Monitoring Outcomes Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 11.0

Eligibility Criteria:
Physician Inclusion Criteria:~* New England Quality Care Alliance (NEQCA) primary care physicians of adult patients insured through large commercial insurer partner~Patient Inclusion Criteria:~* Adult patients of consented New England Quality Care Alliance (NEQCA) primary care physicians~* Insured through large commercial insurer partner~* Prescribed chronic medications for one or more of the three study conditions in the past six months~Patient Exclusion Criterion:~* On the insurer's do not contact list

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Default patient default doctor (Type: EXPERIMENTAL): Patient nonadherence information sent to physician; Pharmacist calls patient unless physician cancels call
- Information patient default doctor (Type: EXPERIMENTAL): Patient nonadherence information sent to physician
- Control patient default doctor (Type: NO_INTERVENTION): Control - no intervention
- Choice patient choice doctor (Type: EXPERIMENTAL): Patient nonadherence information sent to physician; Pharmacist calls patient if physician requests call
- Information patient choice doctor (Type: EXPERIMENTAL): Patient nonadherence information sent to physician
- Control patient choice doctor (Type: NO_INTERVENTION): Control - no intervention
- Information patient information doctor (Type: EXPERIMENTAL): Patient nonadherence information sent to physician
- Control patient information doctor (Type: NO_INTERVENTION): Control - no intervention
- Information doctor (Type: EXPERIMENTAL): Physician receives nonadherence information, but there is no opportunity for pharmacist action
- Choice doctor (Type: EXPERIMENTAL): Physician receives nonadherence information, and can choose to request pharmacist action
- Default doctor (Type: EXPERIMENTAL): Physician receives nonadherence information; pharmacist action will be triggered unless physician cancels action

Based on this trial design, predict the completion outcome and termination type (if applicable).